Just one of many to come moving forward IMO... no upfront fees, but JCR are covering all the trial costs, paying royalties and we get to use the data for submissions outside of Japan ... JCR have been loyal to MSB so I think this is a win win for both parties - just sayin'.
I'm sure naysayers will be all over 'no upfront $$' but most on here will be able to look past that and the other positives from this announcement and realise its value
GLTAH
Ann: MSB Expands Partnership With JCR For Skin Disease, page-4
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |